ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

HHS Draft of Bill Reauthorizing NIH Specifically Kills Bypass Budget, Would End National Cancer Act of 1971

March 29, 1985

Also Unclear whether HHS Secretary Tommy Thompson will depart as previously planned.

November 5, 2004

NCI Program: reports Urges Expansion of Surveillance Program To Better Explain Trends

April 30, 1999

ASCO Is a Society In Transition, Growth; Major changes over Past Year

May 24, 1996

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

April 20, 1990

Tobacco Council Announces 11 New Grant Awards

January 24, 1975